Management of Infection-Caused Myocarditis

Initial Supportive Management

The American College of Cardiology recommends standard guideline-directed medical therapy for heart failure, including ACE inhibitors, beta-blockers, and diuretics as clinically indicated, in patients with reduced ejection fraction 2
The European Heart Society suggests exercise restriction during the acute phase to reduce myocardial oxygen demand and prevent worsening inflammation 3

The American Heart Association recommends temporary pacemaker insertion for symptomatic bradycardia or heart block during the acute phase 4
The American Heart Association suggests antiarrhythmic therapy, such as amiodarone, for symptomatic non-sustained or sustained ventricular tachycardia during acute myocarditis 4
The American Heart Association advises against ICD implantation during the acute phase of myocarditis, as many arrhythmias resolve with recovery 4
The European Heart Society recommends delayed ICD implantation in patients who survive the acute phase but have persistent life-threatening ventricular arrhythmias, provided they have a reasonable expectation of survival with good functional status for more than 1 year 4, 5

The American College of Cardiology recommends aggressive multidrug immunosuppression for giant cell myocarditis, as this rapidly fatal condition has shown improved survival with immunotherapy 4
The American Heart Association suggests corticosteroids as first-line therapy for cardiac sarcoidosis, with alternative immunosuppressive agents for steroid-intolerant patients or those who worsen despite corticosteroids 2

The American College of Cardiology states that the Myocarditis Treatment Trial definitively showed no beneficial effect of prednisone with either azathioprine or cyclosporine in patients with biopsy-proven lymphocytic myocarditis, representing the typical viral myocarditis pattern 1, 6

The European Heart Society recommends endomyocardial biopsy as the gold standard for definitive diagnosis in patients with life-threatening clinical course requiring consideration of immunosuppression 3, 5
The American College of Cardiology suggests that cardiac MRI is a sensitive, non-invasive diagnostic tool that can confirm acute myocarditis and guide biopsy decisions 3, 5

The American College of Cardiology notes that most cases of myocarditis are self-limited with complete recovery, as myocarditis is usually a mild disease where cardiac dysfunction is completely reversible 1, 6
The European Heart Society states that fulminant myocarditis with progressive heart failure is relatively rare but carries high acute mortality 1, 3